FUNDAMENTALS · Fundamentals · US Healthcare

Alphatec Holdings (ATEC) Fundamentals 2026 — Revenue Analysis | SniperIQ

Alphatec Holdings (ATEC) is a US-listed Healthcare company in Medical - Devices with a market capitalization of

.2B, trading at $8.10 on the NASDAQ. This SniperIQ fundamentals page covers Alphatec Holdings's valuation, profitability (net margin -15.9%), revenue ($764M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
.2B
Net Margin-15.9%
Revenue (FY25)$764M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Alphatec Holdings's market cap?

Alphatec Holdings (ATEC) has a market capitalization of approximately

.2B, trading at $8.10 on the NASDAQ. Market cap moves with the live share price.

What is Alphatec Holdings's P/E ratio?

Alphatec Holdings's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 68.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Alphatec Holdings?

Alphatec Holdings runs a net profit margin of -15.9%, a gross margin of 65.3%, and an operating margin of -7.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Alphatec Holdings generate?

Alphatec Holdings reported revenue of $764M for fiscal year 2025, with net income of -

43M and earnings per share (EPS) of -0.96. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Alphatec Holdings pay a dividend?

Alphatec Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Alphatec Holdings financially healthy?

Alphatec Holdings carries a debt-to-equity ratio of 33.03x and a current ratio of 1.90x, with a market beta of 0.85. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Alphatec Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Alphatec Holdings (ATEC) the key facts are: market cap

.2B, revenue $764M, 52-week range 6.82-23.29. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Alphatec Holdings's full fundamentals live

Get Alphatec Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Azenta (AZTA) fundamentals · Ardelyx (ARDX) fundamentals · Intellia Therapeutics (NTLA) fundamentals · STAAR Surgical (STAA) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons